Molecular Diagnostics
Breakthrough Molecular Detection Platform Delivers Best-In-Class Accuracy without Need for Target Amplification
A disruptive new platform that operates with a combination of unprecedented speed and accuracy promises to revolutionize molecular detection and emerge as a new gold standard tool to empower clinical decision-making. More...18 Oct 2023
New
Gold Member
Automatic CLIA Analyzer
Shine i9000
 Analyzer.jpg)
New
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Human Estradiol Assay
Human Estradiol CLIA Kit
In Other News
New Blood Test Could Complement CT Imaging Assessment of Lung Nodules for Cancer Risk
Traumatic Brain Injury Immunoassay to Eliminate Need for Head CT Scans
New Blood Test to Measure Omega-3 Fatty Acids Could Help Evaluate Cardiovascular Risks
Ovarian Cancer Blood Test Distinguishes Between Cancerous and Benign Pelvic Masses With 91% Accuracy
New Technology Makes Diagnosing Serious Geriatric Diseases As Easy As Measuring Blood Sugar
Saliva Test Could Aid Early Detection of Ectopic Pregnancy
Blood-Based Genetic Test Could Help Select Best Treatment for Autoimmune Disease
Urine-Based Genomic Test Identifies Hematuria Patients at High Risk for Bladder Cancer
Liquid Biopsy Test Identifies Over 1,000 Pathogens from Single Blood Draw within 24 Hours
Non-Invasive Tests May Help Identify Patients Facing Higher Risk for Cervical Cancer Recurrence
Fingerprick Blood Test Identifies Individuals Genetically Predisposed to Developing Osteoporosis
Noninvasive Liquid Biopsy Test for Advanced Melanoma Can Track Treatment Response and Tumor Recurrence
Low-Cost, Ultrasensitive Blood Test Detects ‘Pan-Cancer’ Biomarker
Lung Cancer Detection Test Applies Advanced Machine Learning to Whole-Genome Sequencing Data
New Blood Test to Diagnose Concussions Quickly and Accurately
Breakthrough Device That Detects DNA with 100-Fold Greater Sensitivity to Speed Disease Detection
Low-Cost Blood Test to Predict Preterm Preeclampsia during Pregnancy
Innovative Blood Test to Revolutionize Prostate Cancer Detection and Reduce Invasive Biopsies
First Of Its Kind DNA Test Can Assess Predisposition for Dozens of Cancer Types
Pioneering Test Predicts Recurrence and Survival Rates in Breast Cancer Patients
Novel RT-PCR Test Enables Early Detection of Parkinson’s Disease
Novel Non-Invasive Liquid Biopsy Assay Enables Monitoring of Multiple Myeloma Patients
Digital PCR Test Enables More Accurate and Earlier Diagnosis of Preeclampsia in Pregnant Women
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
